NASDAQ:BOLT

Bolt Biotherapeutics . Stock Predictions

Healthcare > Biotechnology

Buy BOLT

*Your capital is at risk

$4.51

-0.0600 (-1.31%)

At Close: Nov 17, 2025

Currently predicting for Wed, 19 Nov 2025

Trading levels for BOLT

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	4.76	5.62%
R2	4.67	3.58%
R1	4.62	2.33%
Price	4.51
S1	4.43	-1.74%
S2	4.38	-2.99%
S3	4.28	-5.03%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	5.31	17.74%
R2	4.96	9.98%
R1	4.57	1.33%
Price	4.51
S1	0	-
S2	0	-
S3	0	-

BOLT Predictions History

3 months ago
paramiparami predicted that BOLT for Aug. 15th is going

Rank:

ABOUT BOLT BIOTHERAPEUTICS, INC.

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for col...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UNIT $6.00	4.83%	Nov 04
TBPH $14.14	27.58%	Oct 23
A AMIX $1.12	2.68%	Oct 23
COCO $40.85	11.21%	Oct 23
LAUR $29.55	1.20%	Oct 22

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by